Cargando…

STARD4 promotes breast cancer cell malignancy

Breast cancer (BRCA) is one of the most common malignancies encountered in women worldwide. Lipid metabolism has been found to be involved in cancer progression. Steroidogenic acute regulatory protein-related lipid transfer 4 (STARD4) is an important cholesterol transporter involved in the regulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Xiang, Zhen, Wang, Feng, Shan, Rong, Li, Ling, Chen, Juan, Liu, Bao-An, Huang, Juan, Sun, Lun-Quan, Zhou, Wei-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610339/
https://www.ncbi.nlm.nih.gov/pubmed/33125124
http://dx.doi.org/10.3892/or.2020.7802
_version_ 1783605176448319488
author Zhang, Min
Xiang, Zhen
Wang, Feng
Shan, Rong
Li, Ling
Chen, Juan
Liu, Bao-An
Huang, Juan
Sun, Lun-Quan
Zhou, Wei-Bing
author_facet Zhang, Min
Xiang, Zhen
Wang, Feng
Shan, Rong
Li, Ling
Chen, Juan
Liu, Bao-An
Huang, Juan
Sun, Lun-Quan
Zhou, Wei-Bing
author_sort Zhang, Min
collection PubMed
description Breast cancer (BRCA) is one of the most common malignancies encountered in women worldwide. Lipid metabolism has been found to be involved in cancer progression. Steroidogenic acute regulatory protein-related lipid transfer 4 (STARD4) is an important cholesterol transporter involved in the regulatory mechanism of intracellular cholesterol homeostasis. However, to the best of our knowledge, the molecular functions of STARD4 in BRCA are unclear. Immunohistochemical staining and public dataset analysis were performed to investigate the expression levels of STARD4 in BRCA. In the present study, high expression of STARD4 was identified in BRCA samples and higher STARD4 expression was significantly associated with shorter distant metastasis-free survival time in patients with BRCA, which indicated that STARD4 may be associated with BRCA progression. Cell cytometry system Celigo(®) analysis, Cell Counting K-8 assays, flow cytometry, wound healing assays and transwell assays were used to investigate the effects of STARD4 knockdown on proliferation, cell cycle, apoptosis and migration in BRCA cells. Loss-of-function assays demonstrated that STARD4 acted as an oncogene to promote proliferation and cell cycle progression, while suppressing apoptosis in BRCA cells in vitro and in vivo. Furthermore, knockdown of STARD4 significantly suppressed BRCA metastasis. To assess the mechanism of action of STARD4, microarray analysis was performed following STARD4 knockdown in MDA-MB-231 cells. The data were analyzed in detail using bioinformatics, and a series of genes, including E74 like ETS transcription factor 1, cAMP responsive element binding protein 1 and p21 (RAC1) activated kinase 2, which have been previously reported to be crucial genes implicated in the malignant phenotype of cancer cells, were identified to be regulated by STARD4. Loss-of function assays demonstrated that knockdown of STARD4 suppressed BRCA proliferation and migration. These findings suggested that STARD4 had an oncogenic effect in human BRCA progression.
format Online
Article
Text
id pubmed-7610339
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-76103392020-11-04 STARD4 promotes breast cancer cell malignancy Zhang, Min Xiang, Zhen Wang, Feng Shan, Rong Li, Ling Chen, Juan Liu, Bao-An Huang, Juan Sun, Lun-Quan Zhou, Wei-Bing Oncol Rep Articles Breast cancer (BRCA) is one of the most common malignancies encountered in women worldwide. Lipid metabolism has been found to be involved in cancer progression. Steroidogenic acute regulatory protein-related lipid transfer 4 (STARD4) is an important cholesterol transporter involved in the regulatory mechanism of intracellular cholesterol homeostasis. However, to the best of our knowledge, the molecular functions of STARD4 in BRCA are unclear. Immunohistochemical staining and public dataset analysis were performed to investigate the expression levels of STARD4 in BRCA. In the present study, high expression of STARD4 was identified in BRCA samples and higher STARD4 expression was significantly associated with shorter distant metastasis-free survival time in patients with BRCA, which indicated that STARD4 may be associated with BRCA progression. Cell cytometry system Celigo(®) analysis, Cell Counting K-8 assays, flow cytometry, wound healing assays and transwell assays were used to investigate the effects of STARD4 knockdown on proliferation, cell cycle, apoptosis and migration in BRCA cells. Loss-of-function assays demonstrated that STARD4 acted as an oncogene to promote proliferation and cell cycle progression, while suppressing apoptosis in BRCA cells in vitro and in vivo. Furthermore, knockdown of STARD4 significantly suppressed BRCA metastasis. To assess the mechanism of action of STARD4, microarray analysis was performed following STARD4 knockdown in MDA-MB-231 cells. The data were analyzed in detail using bioinformatics, and a series of genes, including E74 like ETS transcription factor 1, cAMP responsive element binding protein 1 and p21 (RAC1) activated kinase 2, which have been previously reported to be crucial genes implicated in the malignant phenotype of cancer cells, were identified to be regulated by STARD4. Loss-of function assays demonstrated that knockdown of STARD4 suppressed BRCA proliferation and migration. These findings suggested that STARD4 had an oncogenic effect in human BRCA progression. D.A. Spandidos 2020-12 2020-10-12 /pmc/articles/PMC7610339/ /pubmed/33125124 http://dx.doi.org/10.3892/or.2020.7802 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Min
Xiang, Zhen
Wang, Feng
Shan, Rong
Li, Ling
Chen, Juan
Liu, Bao-An
Huang, Juan
Sun, Lun-Quan
Zhou, Wei-Bing
STARD4 promotes breast cancer cell malignancy
title STARD4 promotes breast cancer cell malignancy
title_full STARD4 promotes breast cancer cell malignancy
title_fullStr STARD4 promotes breast cancer cell malignancy
title_full_unstemmed STARD4 promotes breast cancer cell malignancy
title_short STARD4 promotes breast cancer cell malignancy
title_sort stard4 promotes breast cancer cell malignancy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610339/
https://www.ncbi.nlm.nih.gov/pubmed/33125124
http://dx.doi.org/10.3892/or.2020.7802
work_keys_str_mv AT zhangmin stard4promotesbreastcancercellmalignancy
AT xiangzhen stard4promotesbreastcancercellmalignancy
AT wangfeng stard4promotesbreastcancercellmalignancy
AT shanrong stard4promotesbreastcancercellmalignancy
AT liling stard4promotesbreastcancercellmalignancy
AT chenjuan stard4promotesbreastcancercellmalignancy
AT liubaoan stard4promotesbreastcancercellmalignancy
AT huangjuan stard4promotesbreastcancercellmalignancy
AT sunlunquan stard4promotesbreastcancercellmalignancy
AT zhouweibing stard4promotesbreastcancercellmalignancy